Androgen effects on body composition (Q35197853)

7 August 2017

1 reference

title

Androgen effects on body composition (English)

1 reference

7 August 2017

1

Shalender Bhasin

1 reference

7 August 2017

Linda Woodhouse

2

1 reference

PubMed ID

12914730

7 August 2017

Thomas W Storer

series ordinal

3

1 reference

7 August 2017

1 August 2003

1 reference

Growth Hormone & I G F Research

7 August 2017

1 reference

7 August 2017

13 Suppl A

1 reference

7 August 2017

S63-71

1 reference

Androgen abuse by athletes

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

The anabolic action of testosterone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone Replacement Increases Fat-Free Mass and Muscle Size in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

A COMPARATIVE STUDY OF THE METABOLIC EFFECTS OF TESTOSTERONE PROPIONATE IN NORMAL MEN AND WOMEN AND IN EUNUCHOIDISM

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effect of testosterone on muscle mass and muscle protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Randomized controlled trial of testosterone in myotonic dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone administration to older men improves muscle function: molecular and physiological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Androgen replacement therapy to reverse and/or prevent age-associated sarcopenia in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

A trial of testosterone therapy for HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Androgen therapy in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

The effects of anabolic steroids on growth, body composition, and metabolism in boys with chronic renal failure on regular hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effect of Nandrolone Decanoate on the Anemia of Chronic Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Lack of effects of recombinant growth hormone on muscle function in patients requiring prolonged mechanical ventilation: a prospective, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Proof of the effect of testosterone on skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Modulation of the cytosolic androgen receptor in striated muscle by sex steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone dose-response relationships in healthy young men.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

A possible role for endogenous glucocorticoids in orchiectomy-induced atrophy of the rat levator ani muscle: studies with RU 38486, a potent and selective antiglucocorticoid

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Sexual dimorphism and androgen effects on spinal motoneurons innervating the rat flexor digitorum brevis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Anabolic-androgenic steroid induced alterations in choline acetyltransferase messenger RNA levels of spinal cord motoneurons in the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Quantification of endogenous testosterone, 5 alpha-dihydrotestosterone and 5 alpha-androstane-3 alpha, 17 beta-diol in subcellular fractions of the prostate, bulbocavernosus/levator ani muscle, skeletal muscle and heart muscle of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Low dihydrotestosterone and weight loss in the AIDS wasting syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2803%2900058-3

7 January 2021

10.1016/S1096-6374(03)00058-3

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12914730